Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes

Cardiovascular Diabetology

Volumn 4, Issue , 2005, Pages

  Pollex, Rebecca L ^a   Mamakeesick, Mary ^b   Zinman, Bernard ^c   Harris, Stewart B ^d   Hanley, Anthony J G ^c   Hegele, Robert A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b Sandy Lake Health and Diabetes Project   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ORAL ANTIDIABETIC AGENT;

ABORIGINE; ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CANADA; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; AMERICAN INDIAN; BRACHIAL ARTERY; DIABETIC ANGIOPATHY; ENZYMOLOGY; GENETICS; RISK; RISK FACTOR;

BRACHIAL ARTERY; CANADA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; INTERMITTENT CLAUDICATION; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 27944440112     PISSN: 14752840     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-4-17     Document Type: Article

References (35)

1. Peripheral arterial disease in people with diabetes. Diabetes Care 2003, 26:3333-3341.
2. Jelnes R, Gaardsting O, Hougaard Jensen K, Baekgaard N, Tonnesen KH, Schroeder T: Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed) 1986, 293:1137-1140.
3. Reunanen A, Takkunen H, Aromaa A: Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982, 211:249-256.
4. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH: Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. Jama 1993, 270:487-489.
5. Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB: Decreased ankle/arm blood pressure index and mortality in elderly women. Jama 1993, 270:465-469.
6. Selvin E, Erlinger TP: Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2006. Circulation 2004, 110:738-743.
7. Wattanakit K, Folsom AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL, Hirsch AT: Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2005, 180:389-397.
8. Carter AM, Mansfield MW, Grant PJ: Polymorphisms of platelet glycoproteins in relation to macrovascular disease in type 2 diabetes mellitus. Diabet Med 1998, 15:315-319.
9. Ciccarone E, Di Castelnuovo A, Assanelli D, Archetti S, Ruggeri G, Salcuni N, Donati MB, Capani F, Iacoviello L: Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients. J Thromb Haemost 2003, 1:2540-2547.
10. Hamanishi T, Furuta H, Kato H, Doi A, Tamai M, Shimomura H, Sakagashira S, Nishi M, Sasaki H, Sanke T, Nanjo K: Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients. Diabetes 2004, 53:2455-2460.
11. Koppel H, Krippl P, Gasser R, Wascher TC, Paulweber B, Pilger E, Renner W: Hemochromatosis gene (HFE) polymorphisms are not associated with peripheral arterial disease. Thromb Haemost 2004, 91:1258-1259.
12. Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH: The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 2003, 52:891-894.
13. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC: Peripheral vascular disease in Type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 2003, 20:988-995.
14. Tseng CH, Tseng CP: Lack of association between angiotensin-converting enzyme gene polymorphism and peripheral vascular disease in type 2 diabetic patients in Taiwan. Circ J 2002, 66:1014-1018.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al.: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
16. Malinow MR: Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin Chem 1995, 41:173-176.
17. Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998, 49:31-62.
18. Maeda M, Yamamoto I, Fukuda M, Nishida M, Fujitsu J, Nonen S, Igarashi T, Motomura T, Inaba M, Fujio Y, Azuma J: MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation. Diabetes Care 2003, 26:547-548.
19. Neugebauer S, Baba T, Kurokawa K, Watanabe T: Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 1997, 349:473-474.
20. Sun J, Xu Y, Zhu Y, Lu H, Deng H, Fan Y, Sun S, Zhang Y: The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus. Chin Med J (Engl) 2003, 116:145-147.
21. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I: The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 2005, 50:267-275.
22. Ksiazek P, Bednarek-Skublewska A, Buraczynska M: The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 2004, 10:BR47-51.
23. Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W: Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 2003, 18:1535-1540.
24. Sun J, Xu Y, Zhu Y: [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese]. Zhonghua Nei Ke Za Zhi 2001, 40:529-532.
25. Sun J, Xu Y, Zhu Y, Lu H: Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 2004, 64:185-190.
26. Hasegawa G, Obayashi H, Kamiuchi K, Nakai M, Kanatsuna T, Yamaguchi M, Tanaka T, Shigeta H, Fujii M, Yoshikawa T, Nakamura N: The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2003, 111:132-138.
27. Sun J, Xu Y, Xue J, Zhu Y, Lu H: Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients. Mol Cell Endocrinol 2005, 229:95-101.
28. Doobay AV, Anand SS: The sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes. A systematic review. Arterioscler Thromb Vasc Biol 2005.
29. Hanley AJG, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, McLaughlin JR, Zinman B: Complications of type 2 diabetes among Native Canadians: increasing our understanding of prevalence and risk factors. Canadian J Diabetes 2003, 27:455-463.
30. Hanley AJ, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, Spence JD, House AA, Brown E, Schoales B, et al: Complications of type 2 diabetes among aboriginal Canadians: prevalence and associated risk factors. Diabetes Care 2005, 28:2054-2057.
31. Shinozaki T, Hasegawa T, Yano E: Ankle-arm index as an indicator of atherosclerosis: its application as a screening method. J Clin Epidemiol 1998, 51:1263-1269.
32. Matzke S, Franckena M, Alback A, Railo M, Lepantalo M: Ankle brachial index measurements in critical leg ischaemia--the influence of experience on reproducibility. Scand J Surg 2003, 92:144-147.
33. Rose GA, Blackburn H: Cardiovascular survey methods. Monogr Ser World Health Organ 1968, 56:1-188.
34. Wolever TMS, Hamad S, Gittelsohn J, Hanley AJG, Logan A, Harris SB, Zinman B: Nutrient intake and food use in an Ojibwa-Cree community in northern Ontario assessed by 24 h dietary recall. Nutr Res 1997, 17:603-618.
35. Spence JD, Malinow MR, Barnett PA, Marian AJ, Freeman D, Hegele RA: Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke 1999, 30:969-973.